GB9318880D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB9318880D0
GB9318880D0 GB939318880A GB9318880A GB9318880D0 GB 9318880 D0 GB9318880 D0 GB 9318880D0 GB 939318880 A GB939318880 A GB 939318880A GB 9318880 A GB9318880 A GB 9318880A GB 9318880 D0 GB9318880 D0 GB 9318880D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939318880A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939318880A priority Critical patent/GB9318880D0/en
Publication of GB9318880D0 publication Critical patent/GB9318880D0/en
Priority to PCT/EP1994/002553 priority patent/WO1995007104A1/en
Priority to CN94194082A priority patent/CN1134672A/en
Priority to EP94924832A priority patent/EP0717637A1/en
Priority to JP7508405A priority patent/JPH09502190A/en
Pending legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
GB939318880A 1993-09-11 1993-09-11 Pharmaceutical composition Pending GB9318880D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB939318880A GB9318880D0 (en) 1993-09-11 1993-09-11 Pharmaceutical composition
PCT/EP1994/002553 WO1995007104A1 (en) 1993-09-11 1994-08-02 Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen
CN94194082A CN1134672A (en) 1993-09-11 1994-08-02 Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen
EP94924832A EP0717637A1 (en) 1993-09-11 1994-08-02 Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen
JP7508405A JPH09502190A (en) 1993-09-11 1994-08-02 Encapsulation complex of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318880A GB9318880D0 (en) 1993-09-11 1993-09-11 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB9318880D0 true GB9318880D0 (en) 1993-10-27

Family

ID=10741882

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939318880A Pending GB9318880D0 (en) 1993-09-11 1993-09-11 Pharmaceutical composition

Country Status (5)

Country Link
EP (1) EP0717637A1 (en)
JP (1) JPH09502190A (en)
CN (1) CN1134672A (en)
GB (1) GB9318880D0 (en)
WO (1) WO1995007104A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
US8986735B2 (en) 2006-03-16 2015-03-24 Novartis Ag Solid dosage form containing a taste masked active agent
AU2007230716B2 (en) 2006-03-28 2012-05-03 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
WO2010018777A1 (en) * 2008-08-11 2010-02-18 第一三共株式会社 Odor-controlling method
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5634618A (en) * 1979-08-30 1981-04-06 Ota Seiyaku Kk Production of flurbiprofen preparation
JPS5646838A (en) * 1979-09-27 1981-04-28 Mitsubishi Yuka Yakuhin Kk 2- 2-fluoro-4-biphenylyl propionic acid-cyclodextrin clathrate compound
JPS58126810A (en) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd Ophthalmic anti-inflammatory solution and preparation thereof
FR2647343B1 (en) * 1989-05-24 1994-05-06 Rhone Poulenc Sante NOVEL POROUS PHARMACEUTICAL FORM AND ITS PREPARATION
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
IT1241417B (en) * 1990-03-06 1994-01-14 Vectorpharma Int THERAPEUTIC COMPOSITIONS WITH CONTROLLED RELEASE OF DRUGS SUPPORTED ON CROSS-LINKED POLYMERS AND COATED WITH POLYMER FILM, AND THEIR PREPARATION PROCESS
FR2660195B1 (en) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires PHARMACEUTICAL CHEWING, ANTI-INFLAMMATORY AND / OR ANALGESIC COMPOSITION.
IT1243342B (en) * 1990-07-13 1994-06-10 Farcon Ag ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES

Also Published As

Publication number Publication date
WO1995007104A1 (en) 1995-03-16
CN1134672A (en) 1996-10-30
EP0717637A1 (en) 1996-06-26
JPH09502190A (en) 1997-03-04

Similar Documents

Publication Publication Date Title
HU9402974D0 (en) Pharmaceutical composition
ZA946262B (en) Pharmaceutical compositions
GB9317610D0 (en) Pharmaceutical compositions
GB9316580D0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (en) Pharmaceutical Composition
GB9317504D0 (en) Pharmaceutical compositions
ZA945752B (en) Pharmaceutical composition
GB9221707D0 (en) Pharmaceutical composition
GB9318880D0 (en) Pharmaceutical composition
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
ZA947878B (en) Pharmaceutical compositions
GB9308849D0 (en) Pharmaceutical composition
GB9417021D0 (en) Pharmaceutical composition
HU9303511D0 (en) Pharmaceutical composition
HU9303386D0 (en) Pharmaceutical composition
GB9314564D0 (en) Pharmaceutical composition
GB9321671D0 (en) Pharmaceutical composition
ZA935269B (en) Pharmaceutical composition
ZA947913B (en) Pharmaceutical composition
GB9318350D0 (en) Pharmaceutical composition
GB9314709D0 (en) Pharmaceutical composition
GB9320688D0 (en) Pharmaceutical composition
GB9321203D0 (en) Pharmaceutical compositions